Stay updated on CT103A in Relapsed/Refractory Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the CT103A in Relapsed/Refractory Multiple Myeloma Clinical Trial page.

Latest updates to the CT103A in Relapsed/Refractory Multiple Myeloma Clinical Trial page
- Check3 days agoChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a significant note regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.SummaryDifference4%
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference4%
- Check24 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
- Check31 days agoNo Change Detected
- Check38 days agoChange DetectedThe web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference6%
- Check67 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.3%
- Check74 days agoChange DetectedThe web page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.SummaryDifference1.0%
Stay in the know with updates to CT103A in Relapsed/Refractory Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CT103A in Relapsed/Refractory Multiple Myeloma Clinical Trial page.